Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy

(2022) Ali Baradaran et al.   BIOMEDICINE & PHARMACOTHERAPY

The Activated Macrophage – A Tough Fortress for Virus Invasion: How Viruses Strike Back

(2022) Andra Banete et al.   Frontiers in Microbiology

Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights

(2022) Bhawna Uprety et al.   Cells

Sonographic Features of Triple-Negative Breast Carcinomas Are Correlated With mRNA–lncRNA Signatures and Risk of Tumor Recurrence

(2021) Jia-wei Li et al.   Frontiers in Oncology

Immune checkpoint inhibitors in melanoma

(2021) Matteo S Carlino et al.   LANCET

Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug

(2021) CHARUPONG SAENGBOONMEE et al.   ANTICANCER RESEARCH

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

(2021) Jedd D. Wolchok et al.   JOURNAL OF CLINICAL ONCOLOGY

Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer

(2021) Yonghui Wang et al.   Nanoscale

Pre-activation with TLR7 in combination with thioridazine and loratadine promotes tumoricidal T-cell activity in colorectal cancer

(2020) Xiaotan Lin et al.   ANTI-CANCER DRUGS

Drug Repurposing in Oncology: Current Evidence and Future Direction

(2020) Zhenzhan Zhang et al.   CURRENT MEDICINAL CHEMISTRY

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

(2019) Caroline Robert et al.   LANCET ONCOLOGY

IFIT1 Exerts Opposing Regulatory Effects on the Inflammatory and Interferon Gene Programs in LPS-Activated Human Macrophages

(2018) Sinu P. John et al.   Cell Reports

Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages

(2017) Elisabeth Müller et al.   Frontiers in Immunology

Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value

(2016) Yi-Zhou Jiang et al.   CANCER RESEARCH

High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma

(2016) Jin-feng Zhang et al.   HUMAN PATHOLOGY

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

(2013) Stephanie M Pyonteck et al.   NATURE MEDICINE